We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
-13.46%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$444M
AUM Growth
-$166M
(-27%)
Cap. Flow
-$68M
Cap. Flow
% of AUM
-15.33%
Top 10 Holdings %
Top 10 Hldgs %
54.9%
Holding
59
New
7
Increased
7
Reduced
15
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$24.7M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$16.5M |
| 3 |
Humana
HUM
|
+$15.6M |
| 4 |
Insulet
PODD
|
+$9.32M |
| 5 |
Charter Communications
CHTR
|
+$7.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ross Stores
ROST
|
+$27.9M |
| 2 |
LKQ Corp
LKQ
|
+$16.5M |
| 3 |
GoDaddy
GDDY
|
+$14.1M |
| 4 |
Dollar General
DG
|
+$13.6M |
| 5 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$9.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.43% |
| 2 | Technology | 21.21% |
| 3 | Financials | 8.01% |
| 4 | Communication Services | 7.2% |
| 5 | Consumer Staples | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Charter Communications
CHTR
$17.3B
| $31.9M | 7.2% |
68,159
+15,500
| +29% | +$7.56M |
|
|
2
GoDaddy
GDDY
$10.5B
| $31M | 6.99% |
445,953
-185,700
| -29% | -$14.1M |
|
3
Centene
CNC
$30.6B
| $26.9M | 6.07% |
318,300
-33,300
| -9% | -$2.77M |
|
4
Morgan Stanley
MS
$334B
| $26M | 5.87% |
342,214
-32,378
| -9% | -$2.65M |
|
|
5
AstraZeneca
AZN
$265B
| $24.9M | 5.61% |
+188,300
| New | +$24.7M |
|
6
Clarivate
CLVT
$1.23B
| $22.7M | 5.13% |
1,641,319
-198,961
| -11% | -$2.98M |
|
7
Alcon
ALC
$33.4B
| $21.9M | 4.93% |
313,115
-40,100
| -11% | -$2.93M |
|
8
Vertex Pharmaceuticals
VRTX
$120B
| $20.6M | 4.64% |
73,072
-9,728
| -12% | -$2.6M |
|
9
Uber
UBER
$142B
| $20.3M | 4.58% |
993,309
-23,100
| -2% | -$613K |
|
|
10
BioMarin Pharmaceuticals
BMRN
$11.5B
| $17.2M | 3.88% |
+207,800
| New | +$16.5M |
|
|
11
Humana
HUM
$44.5B
| $16.4M | 3.69% |
+35,000
| New | +$15.6M |
|
12
Caesars Entertainment
CZR
$6.05B
| $15.8M | 3.55% |
411,753
-8,300
| -2% | -$462K |
|
13
VeriSign
VRSN
$26.1B
| $15.7M | 3.54% |
93,753
-28,561
| -23% | -$5.24M |
|
14
SkinHealth Systems
SKIN
$85.4M
| $14.1M | 3.17% |
1,094,710
+164,500
| +18% | +$2.2M |
|
15
iRhythm Holdings
IRTC
$3.88B
| $12.9M | 2.92% |
119,779
-38,700
| -24% | -$5.13M |
|
|
PSPC.U
16
DELISTED
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
| $12.2M | 2.75% |
1,250,000
| – | – |
|
17
Teva Pharmaceuticals
TEVA
$40.6B
| $11.3M | 2.54% |
1,500,000
| – | – |
|
18
Ironwood Pharmaceuticals
IRWD
$680M
| $11M | 2.48% |
956,014
+26,300
| +3% | +$310K |
|
|
AVAN.U
19
DELISTED
Avanti Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
AVAN.U
| $10M | 2.25% |
1,000,000
| – | – |
|
20
AirSculpt Technologies
AIRS
$327M
| $9.7M | 2.19% |
1,634,941
| – | – |
|
|
WRAC
21
DELISTED
Williams Rowland Acquisition Corp.
WRAC
| $9.5M | 2.14% |
950,000
| – | – |
|
|
22
Insulet
PODD
$11.4B
| $8.94M | 2.01% |
+41,000
| New | +$9.32M |
|
23
Post Holdings
POST
$4.18B
| $8.26M | 1.86% |
100,298
-47,300
| -32% | -$3.67M |
|
24
Sable Offshore Corp
SOC
$953M
| $4.89M | 1.1% |
500,000
| – | – |
|
25
RxSight
RXST
$247M
| $4.67M | 1.05% |
331,432
+132,832
| +67% | +$1.75M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q2 2022 Portfolio in Review
As of Q2 2022, Bridger Management held 59 positions worth $444M, down 27% from $610M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Bridger Management withdrew a net $68M in Q2 2022, closing 16 positions and reducing 15 holdings. Its most notable exit was Ross Stores, an estimated $27.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 34% a quarter earlier, followed by Technology and Financials.
Against the trend, Bridger Management opened a new position in AstraZeneca worth $24.9M.
- Bridger Management's largest Q2 2022 buy was AstraZeneca: 188,300 shares worth $24.9M.
- Bridger Management added most to Charter Communications in Q2 2022, an estimated $7.56M increase.
- Bridger Management's biggest Q2 2022 reduction was GoDaddy, cutting an estimated $14.1M.
- Bridger Management fully exited Ross Stores in Q2 2022, selling an estimated $27.9M.
- Bridger Management's ten largest holdings make up 55% of its $444M portfolio in Q2 2022.
- Bridger Management opened 7 new positions and closed 16 in Q2 2022.
- Bridger Management's portfolio value fell 27% quarter-over-quarter to $444M.
Based on Bridger Management's 13F filing for Q2 2022, filed 15 Aug 2022.